Trials / Completed
CompletedNCT00261911
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
A 12 Month Study to Assess Safety and Efficacy of Meridia (Sibutramine Hydrochloride Monohydrate) 10 and 15 mg in Obese Adolescents
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 498 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 12 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effectiveness of sibutramine on weight loss, reduction in body size and improvement in metabolic risk factors and safety in obese adolescents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sibutramine |
Timeline
- Start date
- 2000-07-01
- Completion
- 2002-02-01
- First posted
- 2005-12-06
- Last updated
- 2007-08-31
Source: ClinicalTrials.gov record NCT00261911. Inclusion in this directory is not an endorsement.